CORONA REMEDIES PVT LTD

The revenue count during FY 20-21 for Ahmedabadbased Corona Remedies was Rs 15 crore in the biopharma space, marking a decline of 21 per cent when compared to the revenue generated during the FY 19-20 at Rs 19 crore. For Corona, cardio metabolic and nutraceuticals segments are the focus areas, while it has a significant presence in the gynecology, infertility and neuropathy segments. The company has a state-of-theart manufacturing facility spread over 30,000+ sq. ft. at Solan, Himachal Pradesh. The plant also has isolated and dedicated production facilities of general, cephalosporin and hormonal dosage forms.